Transfecting full-length genomes into MAVS-/- MLT cells expressing miR-122 and the human HCV entry factors resulted in robust replication and infectious particle production; however, in performing infections, replication declined and infectious particle release fell below background levels (Frentzen et al., 2014). The gene discussed is MAVS; the disease is infection.